TAR-200, a small drug-releasing implant, wiped out tumors in most patients with high-risk bladder cancer. Its slow, ...
Viktor Larkhill on MSN
How Eros survived surgery after his bladder was full of stones
This surgery was one of the most intense we’ve ever done. Eros’s bladder was completely blocked, but the vets didn’t give up.
The IMvigor010 trial showed that Signatera-guided treatment with Tecentriq improved disease-free survival and overall ...
The trial showed that 63% of patients achieved a complete response (CR) at any time after receiving detalimogene coraplasmid.
The TAR‑200 slow‑release bladder implant cleared tumours in 82% of patients with high‑risk non‑muscle‑invasive bladder cancer ...
Welltica+ on MSN
Tiny implant eliminates bladder cancer in 82% of patients
A new slow-release implant has shown unprecedented success in wiping out bladder cancer in more than 80 percent of patients, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback